Literature DB >> 16651760

Spectrofluorimetric and spectrophotometric stability-indicating methods for determination of some oxicams using 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD-Cl).

Elham Anwer Taha1, Nahla Nour Salama, Laila El-Sayed Abdel Fattah.   

Abstract

Two sensitive and selective spectrofluorimetric and spectrophotometric stability-indicating methods have been developed for the determination of some non-steroidal anti-inflammatory oxicam derivatives namely lornoxicam (Lx), tenoxicam (Tx) and meloxicam (Mx) after their complete alkaline hydrolysis. The methods are based on derivatization of alkaline hydrolytic products with 7-chloro-4-nitrobenz-2-oxa-1,3-diazole (NBD-Cl). The products showed an absorption maximum at 460 nm for the three studied drugs and fluorescence emission peak at 535 nm in methanol. The color was stable for at least 48 h. The optimum conditions of the reaction were investigated and it was found that the reaction proceeds quantitatively at pH 8, after heating in a boiling water bath for 30 min. The methods were found to be linear in the ranges of 1-10 microg ml(-1) for Lx and Tx and 0.5-4.0 microg ml(-1) for Mx for spectrophotometric method, while 0.05-1.0 microg ml(-1) for Lx and Tx and 0.025-0.4 microg ml(-1) for Mx for the spectrofluorimetric method. The validity of the methods was assessed according to USP guidelines. Statistical analysis of the results revealed high accuracy and good precision. The suggested procedures could be used for the determination of the above mentioned drugs in pure and dosage forms as well as in the presence of their degradation products.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16651760     DOI: 10.1248/cpb.54.653

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  8 in total

1.  Determination of meloxicam using europium sensitized luminescence in the presence of co-luminescence reagents.

Authors:  Salma Muhamed Z Al-Kindy; Salim K Al-Habsy; Fakhr Eldin O Suliman; Haidar A J Al-Lawati
Journal:  J Fluoresc       Date:  2011-09-22       Impact factor: 2.217

2.  Spectrofluorimetric determination of paroxetine HCl in pharmaceuticals via derivatization with 4-chloro-7- nitrobenzo-2-oxa-1,3-diazole (NBD-Cl).

Authors:  M Walsh; F Belal; Nahed El-Enany; H Elmansi
Journal:  J Fluoresc       Date:  2010-07-01       Impact factor: 2.217

3.  Investigation on the micelle-sensitized Ce(IV)-lornoxicam-Rh B chemiluminescence system and its application.

Authors:  Fang Zhao; Wenhui Zhao
Journal:  J Fluoresc       Date:  2011-10-04       Impact factor: 2.217

4.  Spectrofluorimetric methods for the determination of gemifloxacin in tablets and spiked plasma samples.

Authors:  Serife Evrim Kepekci Tekkeli; Armağan Önal
Journal:  J Fluoresc       Date:  2010-10-28       Impact factor: 2.217

5.  Thiosemicarbazide functionalized carbon quantum dots as a fluorescent probe for the determination of some oxicams: application to dosage forms and biological fluids.

Authors:  Mona E El Sharkasy; Manar M Tolba; Fathalla Belal; Mohamed I Walash; Rasha Aboshabana
Journal:  RSC Adv       Date:  2022-05-09       Impact factor: 4.036

6.  Spectrofluorimetric determination of fluvoxamine in dosage forms and plasma via derivatization with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole.

Authors:  Ibrahim A Darwish; Sawsan M Amer; Heba H Abdine; Lama I Al-Rayes
Journal:  J Fluoresc       Date:  2008-10-23       Impact factor: 2.217

7.  New spectrofluorimetric method with enhanced sensitivity for determination of paroxetine in dosage forms and plasma.

Authors:  Ibrahim A Darwish; Sawsan M Amer; Heba H Abdine; Lama I Al-Rayes
Journal:  Anal Chem Insights       Date:  2008-11-18

8.  Development and Validation of HPTLC Method for Estimation of Tenoxicam and its Formulations.

Authors:  S Chandel; C R Barhate; A R Srivastava; S R Kulkarni; S K Kulkarni; C J Kapadia
Journal:  Indian J Pharm Sci       Date:  2012-01       Impact factor: 0.975

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.